ACRS
Price
$1.44
Change
-$0.01 (-0.69%)
Updated
Jul 3 closing price
Capitalization
155.92M
30 days until earnings call
ITRM
Price
$0.96
Change
-$0.01 (-1.03%)
Updated
Jul 3 closing price
Capitalization
38.56M
32 days until earnings call
Interact to see
Advertisement

ACRS vs ITRM

Header iconACRS vs ITRM Comparison
Open Charts ACRS vs ITRMBanner chart's image
Aclaris Therapeutics
Price$1.44
Change-$0.01 (-0.69%)
Volume$402.41K
Capitalization155.92M
Iterum Therapeutics
Price$0.96
Change-$0.01 (-1.03%)
Volume$491.96K
Capitalization38.56M
ACRS vs ITRM Comparison Chart in %
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. ITRM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and ITRM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ACRS: $1.44 vs. ITRM: $0.96)
Brand notoriety: ACRS and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRS: 43% vs. ITRM: 90%
Market capitalization -- ACRS: $155.92M vs. ITRM: $38.56M
ACRS [@Biotechnology] is valued at $155.92M. ITRM’s [@Biotechnology] market capitalization is $38.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACRS and ITRM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 5 TA indicator(s) are bullish while ITRM’s TA Score has 3 bullish TA indicator(s).

  • ACRS’s TA Score: 5 bullish, 4 bearish.
  • ITRM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACRS is a better buy in the short-term than ITRM.

Price Growth

ACRS (@Biotechnology) experienced а -7.69% price change this week, while ITRM (@Biotechnology) price change was -5.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.52%. For the same industry, the average monthly price growth was +13.89%, and the average quarterly price growth was -0.53%.

Reported Earning Dates

ACRS is expected to report earnings on Aug 06, 2025.

ITRM is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+5.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($156M) has a higher market cap than ITRM($38.6M). ACRS YTD gains are higher at: -41.935 vs. ITRM (-45.542). ITRM has higher annual earnings (EBITDA): -19.12M vs. ACRS (-53.49M). ACRS has more cash in the bank: 105M vs. ITRM (12.7M). ACRS has higher revenues than ITRM: ACRS (17.8M) vs ITRM (0).
ACRSITRMACRS / ITRM
Capitalization156M38.6M404%
EBITDA-53.49M-19.12M280%
Gain YTD-41.935-45.54292%
P/E RatioN/AN/A-
Revenue17.8M0-
Total Cash105M12.7M827%
Total DebtN/A32M-
FUNDAMENTALS RATINGS
ACRS vs ITRM: Fundamental Ratings
ACRS
ITRM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACRS's Valuation (21) in the Pharmaceuticals Other industry is significantly better than the same rating for ITRM (88) in the Biotechnology industry. This means that ACRS’s stock grew significantly faster than ITRM’s over the last 12 months.

ACRS's Profit vs Risk Rating (99) in the Pharmaceuticals Other industry is in the same range as ITRM (100) in the Biotechnology industry. This means that ACRS’s stock grew similarly to ITRM’s over the last 12 months.

ACRS's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as ITRM (99) in the Biotechnology industry. This means that ACRS’s stock grew similarly to ITRM’s over the last 12 months.

ACRS's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as ITRM (64) in the Biotechnology industry. This means that ACRS’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ACRS (100) in the Pharmaceuticals Other industry. This means that ITRM’s stock grew significantly faster than ACRS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACRSITRM
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 28 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PXLW7.220.05
+0.70%
Pixelworks Inc
DE520.970.66
+0.13%
Deere & Company
PMT13.23N/A
N/A
PennyMac Mortgage Investment Trust
MZTI180.02-1.55
-0.85%
The Marzetti Company
CURI4.82-0.05
-1.13%
CuriosityStream

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with MYNZ. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then MYNZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
-0.69%
MYNZ - ACRS
40%
Loosely correlated
N/A
IBRX - ACRS
34%
Loosely correlated
+3.03%
ARCT - ACRS
33%
Poorly correlated
+1.17%
RXRX - ACRS
32%
Poorly correlated
+1.15%
PDSB - ACRS
32%
Poorly correlated
+4.72%
More

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with ACRS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-0.42%
ACRS - ITRM
34%
Loosely correlated
-0.69%
TARA - ITRM
34%
Loosely correlated
+3.96%
TRDA - ITRM
27%
Poorly correlated
N/A
IBRX - ITRM
26%
Poorly correlated
+3.03%
LGVN - ITRM
26%
Poorly correlated
+0.77%
More